Provided by Tiger Trade Technology Pte. Ltd.

Propanc Biopharma, Inc.

1.11
-0.0450-3.90%
Volume:9K
Turnover:10.22K
Market Cap:2.53M
PE:-0.03
High:1.14
Open:1.14
Low:1.08
Close:1.16
52wk High:85.50
52wk Low:0.9500
Shares:2.28M
Float Shares:269.40K
Volume Ratio:1.18
T/O Rate:3.39%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-32.4560
EPS(LYR):-371.2241
ROE:-126.98%
ROA:-62.31%
PB:0.26
PE(LYR):0.00

Loading ...

Apr 08, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Apr 02, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Mar 31, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Mar 18, 2025

Major Issues Report

Form 8-K - Current report
Feb 14, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 12, 2025

Major Issues Report

Form 8-K - Current report
Dec 20, 2024

Major Issues Report

Form 8-K - Current report
Dec 06, 2024

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 30, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Sep 30, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Sep 27, 2024

Major Issues Report

Form 8-K - Current report
Aug 30, 2024

Major Issues Report

Form 8-K - Current report
Aug 15, 2024

Major Issues Report

Form 8-K - Current report
Aug 07, 2024

Major Issues Report

Form 8-K - Current report
Jul 02, 2024

Major Issues Report

Form 8-K - Current report
Jun 21, 2024

Major Issues Report

Form 8-K - Current report
Jun 13, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Jun 12, 2024

Major Issues Report

Form 8-K - Current report
Jun 05, 2024

Major Issues Report

Form 8-K - Current report